OpenAI boosts GPT‑Rosalind with advanced drug‑discovery and genomics abilities
OpenAI upgraded GPT‑Rosalind, merging GPT‑3.5's agentic coding tools with deeper expertise in medicinal chemistry, genomics, and experimental workflows. The model now outperforms prior versions on LifeSciBench, a new benchmark covering evidence handling, design, reasoning, and validation across life‑science tasks. It is available in research preview via trusted‑access deployment.